Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Do lipid-lowering agents provide a greater reduction in cardiovascular events among patients with diabetes?

    Gollapudi AK.

    Ann Intern Med. 2008 Dec 2;149(11):841; author reply 841-2. No abstract available. PMID: 19047040 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

    Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators.

    Lancet. 2005 Nov 26;366(9500):1849-61. Erratum in: Lancet. 2006 Oct 21;368(9545):1415. Lancet. 2006 Oct 21;368(9545):1420. PMID: 16310551 [PubMed - indexed for MEDLINE]Related articles

    3.

    The evidence for lipid lowering: type 2 diabetes and coronary heart disease risk.

    Townsend D, Davis R.

    Prof Nurse. 2004 Jun;19(10):38-40. Review.PMID: 15233071 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lipid disorders in NIDDM: implications for treatment.

    Taskinen MR, Smith U.

    J Intern Med. 1998 Nov;244(5):361-70. Review.PMID: 9845851 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.

    Costa J, Borges M, David C, Vaz Carneiro A.

    BMJ. 2006 May 13;332(7550):1115-24. Epub 2006 Apr 3. Review.PMID: 16585050 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes.

    Karalis DG.

    Clin Cardiol. 2008 Jun;31(6):241-8. Review.PMID: 17847038 [PubMed - indexed for MEDLINE]Related articles

    7.

    Status report of lipid-lowering trials in diabetes.

    Betteridge DJ, Colhoun H, Armitage J.

    Curr Opin Lipidol. 2000 Dec;11(6):621-6.PMID: 11086336 [PubMed - indexed for MEDLINE]Related articles

    8.

    A case for lipid-lowering?

    Durrington P.

    Diabet Med. 2000 Sep;17 Suppl 2:4-5. No abstract available. PMID: 11048824 [PubMed - indexed for MEDLINE]Related articles

    9.

    Management of hypercholesterolaemia in the patient with diabetes.

    Packard C, Olsson AG.

    Int J Clin Pract Suppl. 2002 Jul;(130):27-32. Review.PMID: 12296606 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study.

    James P, Tan HH, MacAlpine R, Brennan G, Emslie-Smith A, Morris AD.

    Diabet Med. 2004 Oct;21(10):1108-12.PMID: 15384958 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of lipids and type 2 diabetes.

    Hermayer KL.

    Curr Cardiol Rep. 2004 Nov;6(6):443-50. Review.PMID: 15485606 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?

    Feher MD, Elkeles RS.

    Heart. 1999 Jan;81(1):10-1. No abstract available. PMID: 10220537 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2]

    Wolffenbuttel BH, Huijberts MS.

    Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):761-5. Dutch. PMID: 11346911 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials.

    Allemann S, Diem P, Egger M, Christ ER, Stettler C.

    Curr Med Res Opin. 2006 Mar;22(3):617-23.PMID: 16574044 [PubMed - indexed for MEDLINE]Related articles

    15.

    Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes.

    Gosavi A, Flaker G, Gardner D.

    Prev Cardiol. 2006 Spring;9(2):102-7; quiz 108-9. Review.PMID: 16603829 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.

    Hobbs FD.

    Int J Cardiol. 2006 Jun 16;110(2):137-45. Epub 2005 Nov 11. Review.PMID: 16289373 [PubMed - indexed for MEDLINE]Related articles

    17.

    Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

    Nesto RW.

    Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treating lipid abnormalities in patients with type 2 diabetes mellitus.

    Steiner G.

    Am J Cardiol. 2001 Dec 20;88(12A):37N-40N. Review.PMID: 11788129 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dyslipidemia in type 2 diabetes mellitus.

    Gadi R, Samaha FF.

    Curr Diab Rep. 2007 Jun;7(3):228-34. Review.PMID: 17547840 [PubMed - indexed for MEDLINE]Related articles

    20.

    Lipids and diabetes mellitus: a review of therapeutic options.

    Goguen JM, Leiter LA.

    Curr Med Res Opin. 2002;18 Suppl 1:s58-74. Review.PMID: 12365820 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data